Elevance Health Inc. Profile Avatar - Palmy Investing

Elevance Health Inc.

Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people…
Medical - Healthcare Plans
US, Indianapolis [HQ]

Ratios

15 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 98.09 92.65 92.14 91.68 89.91
Profit Margin
7.30 4.91 4.36 4.30 3.51 3.48 3.23 2.91 4.27 4.07 4.61 3.75 4.44 3.76 3.49
Operating Margin
11.38 7.40 6.52 6.26 5.41 5.91 5.85 5.37 4.40 5.50 5.74 5.12 5.72 4.96 - -
EPS Growth
111.00 -27.58 2.09 11.67 -2.53 12.84 2.30 -4.49 60.36 -1.73 27.53 -3.08 37.36 -1.92 3.34
Return on Assets (ROA)
9.10 5.75 5.09 4.50 4.18 4.14 4.15 3.79 5.45 5.24 6.21 5.28 6.33 5.74 5.50
Return on Equity (ROE)
19.09 12.12 11.36 11.16 10.05 10.60 11.11 9.84 14.50 13.14 15.15 13.77 17.08 16.23 15.23
Return on Invested Capital (ROIC)
14.27 8.81 8.00 6.85 6.71 6.50 6.58 6.05 8.28 7.85 9.28 8.59 10.31 9.96 - -
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
16.11 17.85 18.83 25.41 24.33 24.41 25.71 24.16 28.26 26.84 25.93 23.13 23.67 23.46 23.06
Debt/Equity
33.78 37.60 42.06 62.93 58.52 62.48 68.84 62.66 75.21 67.31 63.30 60.35 63.87 66.42 63.91
Debt/EBITDA
47.71 160.76 165.26 271.23 271.84 249.10 248.26 213.12 336.26 246.60 212.81 193.37 196.72 177.12 1,068.01
Debt/Capitalization
25.25 27.33 29.61 38.62 36.91 38.45 40.77 38.52 42.92 40.23 38.76 37.64 38.98 39.91 38.99
Interest Debt per Share USD
18.31 24.81 30.13 50.83 51.47 58.76 63.23 62.37 80.72 78.51 81.53 83.01 97.74 104.02 110.85
Debt Growth
-5.01 6.60 9.40 52.91 -3.25 4.56 4.70 -0.87 26.74 -3.62 4.55 -0.25 14.95 4.70 4.17
Liquidity
Current Ratio
218.68 123.75 122.66 218.88 211.65 213.15 209.90 209.30 181.40 195.69 215.10 213.34 207.24 140.11 143.64
Quick Ratio
238.21 497.21 438.15 218.88 211.65 213.15 209.90 209.30 181.40 195.69 215.10 213.34 207.24 124.40 129.23
Cash Ratio
117.33 38.56 40.58 22.42 14.01 17.06 16.81 28.60 21.97 25.70 30.19 30.52 22.68 18.61 15.62
Operating Cash Flow Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
- - - - - - - - - - - - - - - - - - - - -6.86 -26.08 -28.31 -114.53 -37.32
Receivables Turnover
1,562.99 1,487.71 1,363.49 1,273.80 1,348.28 1,018.76 1,078.31 990.68 1,023.96 989.21 987.52 1,112.13 1,031.54 976.04 959.08
Payables Turnover
- - - - - - - - - - - - - - - - - - - - 15.28 53.13 58.93 63.18 75.12
Asset Turnover
124.75 117.21 116.71 104.68 119.22 119.03 128.26 130.39 127.64 128.69 134.55 140.70 142.48 152.37 157.30
Coverage
Interest Coverage
1,654.67 1,039.34 919.80 755.28 637.17 727.17 709.19 630.07 536.37 673.04 802.28 795.66 993.11 912.93 -0.39
Asset Coverage
400 400 400 200 200 200 200 200 200 200 200 200 200 200 200
Cash Flow Coverage (CFGR)
36.18 15.82 34.45 18.32 21.06 22.24 25.94 20.38 21.00 19.92 30.18 53.35 36.32 34.83 32.09
EBITDA Coverage
1,600 1,000 1,000 900 700 800 800 700 600 800 900 900 1,100 1,100 100
Dividend Coverage
- - - - -700 -700 -500 -500 -300 -300 -500 -400 -500 -400 -500 -400 -400
Time Interest Earned (TIE)
600 600 700 700 700 600 600 600 700 -100 -100 - - 800 800 400
Market Prospects
Dividend Yield
- - - - 1.59 1.98 1.65 1.43 1.80 1.80 1.22 1.16 1.06 1.18 0.98 1.00 1.25
Earnings Yield
16.85 13.44 11.77 14.31 9.19 7.63 7.03 6.51 6.67 5.62 6.23 5.68 5.45 4.79 5.38
Price/Earnings (P/E)
593.47 743.93 849.49 699.05 1,088.31 1,311.18 1,422.93 1,535.31 1,499.47 1,780.98 1,605.34 1,761.36 1,835.19 2,088.78 1,858.04
Price/Book (P/B)
113.28 90.20 96.54 77.99 109.41 138.93 158.08 151.07 217.42 234.00 243.22 242.57 313.40 339.09 283.01
Price/Sales (P/S)
43.31 36.53 37.03 30.08 38.15 45.61 46.02 44.68 64.00 72.51 74.05 66.08 81.51 78.62 64.92
Price/Cash Flow (P/CF)
926.84 1,516.07 666.29 676.36 887.71 1,000.01 885.01 1,183.30 1,376.93 1,745.15 1,273.20 753.46 1,351.16 1,465.80 1,379.99
End of ELV's Analysis
CIK: 1156039 CUSIP: 036752103 ISIN: US46138E2972 LEI: - UEI: -
Secondary Listings